484 Followers on Owler

Precigen

is a Maryland-based clinical stage biopharmaceutical company that develops gene and cellular therapies for the treatment of immuno-oncology and autoimmune disorders... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Precigen

is a Maryland-based clinical stage biopharmaceutical company that develops gene and cellular therapies for the treatment of immuno-oncology and autoimmune disorders... Read more
Precigen President & CEO: Helen Sabzevari

President & CEO

Helen Sabzevari

CEO Approval Rating

90/100

1998

PublicIndependent CompanyNASDAQPGEN

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
8000 NAICS listing

Annual Revenue
$3.9M
Employees
190
Funding
$1.1B
Acquisitions
6

News

Partnership
Apr 16, 2025
StreetInsider
Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th
Conference Presentation
Jan 09, 2025
Yahoo
Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Precigen Competitors

1Bristol-Myers Squibb
2Tmunity
3Anixa Biosciences
4Novartis
5Gilead
6Adaptimmune
7GSK
8Kite Pharma
9Incyte
10Poseida
Unlock 12 + competitors

Trending Companies